2,250
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Construction of a stable w/o nano-emulsion as a potential adjuvant for foot and mouth disease virus vaccine

, , , &
Pages 897-906 | Received 31 Mar 2016, Accepted 07 May 2016, Published online: 20 Jun 2016

References

  • Arellano A, Santoyo S, Martın C, et al. 1999. Influence of propylene glycol and isopropyl myristate on the in vitro percutaneous penetration of diclofenac sodium from carbopol gels. Eur J Pharm Sci. 7:129–135.
  • Bonnet M, Cansell M, Berkaoui A, et al. 2009. Release rate profiles of magnesium from multiple W/O/W emulsions. Food Hydrocolloids 23:92–101.
  • Cao Y. 2014. Adjuvants for foot-and-mouth disease virus vaccines: recent progress. Exp Rev Vaccines 13:1377–1385.
  • Cheng CJ, Chu LY, Xie R. 2006. Preparation of highly monodisperse W/O emulsions with hydrophobically modified SPG membranes. J Colloid Interface Sci. 300:375–382.
  • Graves JH. 1963. Formalin-treated foot-and-mouth disease virus: comparison of two adjuvants in cattle. Can J Comp Med Vet Sci. 27:193–197.
  • Dar P, Kalaivanan R, Sied N, et al. 2013. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle. Vaccine 31:3327–3332.
  • Fechner A, Knoth A, Scherze I, et al. 2007. Stability and release properties of double-emulsions stabilised by caseinate–dextran conjugates. Food Hydrocolloids 21:943–952.
  • Gaiti N, Aserin A, Cohen Y. 1994. Mechanistic considerations on the release of electrolytes from multiple emulsions stabilized by BSA and nonionic surfactants. J Control Release 29:41–51.
  • Goldberg-Cettina M, Liu P, Nightingale J, et al. 1995. Enhanced transdermal delivery of estradiol in vitro using binary vehicles of isopropyl myristate and short-chain alkanols. Int J Pharmaceut. 114:237–245.
  • Gülseren İ, Corredig M. 2012. Interactions at the interface between hydrophobic and hydrophilic emulsifiers: polyglycerol polyricinoleate (PGPR) and milk proteins, studied by drop shape tensiometry. Food Hydrocolloids 29:193–198.
  • Gupta RK, Relyveld EH, Lindblad EB, et al. 1993. Adjuvants – a balance between toxicity and adjuvanticity. Vaccine 11:293–306.
  • He QG, Chen HC, Wu B, et al. 2007. Detection of serum antibody against hog cholera, porcine parvovirus and the foot-and-mouth disease on 44 pig farms of six provinces. Chin J Pre Vet Med. 22:5–9.
  • Jin H, Li Y, Ma Z, et al. 2004. Effect of chemical adjuvants on DNA vaccination. Vaccine 22:2925–2935.
  • Krstonošić V, Dokić L, Dokić P, et al. 2009. Effects of xanthan gum on physicochemical properties and stability of corn oil-in-water emulsions stabilized by polyoxyethylene (20) sorbitan monooleate. Food Hydrocolloids 23:2212–2218.
  • Leclercq SY, dos Santos RMM, Macedo LB, et al. 2011. Evaluation of water-in-oil-in-water multiple emulsion and microemulsion as potential adjuvants for immunization with rabies antigen. Eur J Pharm Sci. 43:378–385.
  • Márquez AL, Palazolo GG, Wagner JR. 2007. Water in oil (w/o) and double (w/o/w) emulsions prepared with spans: microstructure, stability, and rheology. Colloid Polym Sci. 285:1119–1128.
  • Márquez AL, Medrano A, Panizzolo LA, et al. 2010. Effect of calcium salts and surfactant concentration on the stability of water-in-oil (w/o) emulsions prepared with polyglycerol polyricinoleate. J Colloid Interface Sci. 341:101–108.
  • Matos M, Gutiérrez G, Coca J, et al. 2014. Preparation of water-in-oil-in-water (W 1/O/W 2) double emulsions containing trans-resveratrol. Colloid Surface A 442:69–79.
  • McClements DJ. 2004. Food Emulsions, Principles, Practices and Techniques. Boca Raton (FL): CRC Press Inc.
  • McKercher PD, Farris Jr HE. 1967. Foot-and-mouth disease in swine: response to inactivated vaccines. Arch Gesamte Virusforsch. 22:451–461.
  • Mengual O, Meunier G, Cayré I, et al. 1999. TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis. Talanta 50:445–456.
  • Michelsen E. 1961. Experience with vaccination of pigs. Arch Exp Vet Med. 15:317–321.
  • Murray R, Cohen P, Hardegree MC. 1972. Mineral oil adjuvants: biological and chemical studies. Ann Allergy 30:146–151.
  • Park ME, Lee SY, Kim RH, et al. 2014. Enhanced immune responses of foot-and-mouth disease vaccine using new oil/gel adjuvant mixtures in pigs and goats. Vaccine 32:5221–5227.
  • Porras M, Solans C, Gonzalez C, et al. 2004. Studies of formation of W/O nano-emulsions. Colloid Surface A 249:115–118.
  • Potter M, Boyce CR. 1962. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature 193:1086–1087.
  • Rao MG, Butchaiah G, Sen AK. 1994. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1. Vet Microbiol. 39:135–143.
  • Salk JE, Contakos M, Laurent AM, et al. 1953. Use of adjuvants in studies on influenza immunization. III. Degree of persistence of antibody in human subjects two years after vaccination. J Am Med Assoc. 151:1169–1175.
  • Shi XJ, Wang B, Wang M. 2007. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model. Vaccine 25:1257–1264.
  • Stewart-Tull DES, Shimono T, Kotani S, et al. 1976. Immunosuppressive effect in mycobacterial adjuvant emulsions of mineral oils containing low molecular weight hydrocarbons. Int Arch Allergy Appl Immunol. 52:118–128.
  • Su J, Flanagan J, Hemar Y, et al. 2006. Synergistic effects of polyglycerol ester of polyricinoleic acid and sodium caseinate on the stabilisation of water–oil–water emulsions. Food Hydrocolloids 20:261–268.
  • Terhuja M, Saravanan P, Tamilselvan RP. 2015. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs. Biologicals 43:437–443.
  • Ushikubo FY, Cunha RL. 2014. Stability mechanisms of liquid water-in-oil emulsions. Food Hydrocolloids 34:145–153.
  • Wei DS. 2007. Discussion on the failure of vaccination in animals. J Anim Sci Vet Med. 26:33–34.
  • Wilson R, Van Schie BJ, Howes D. 1998. Overview of the preparation, use and biological studies on polyglycerol polyricinoleate (PGPR). Food Chem Toxicol. 36:711–718.
  • Xiao C, Rajput ZI, Hu S. 2007. Improvement of a commercial foot-and-mouth disease vaccine by supplement of Quil A. Vaccine 25:4795–4800.
  • Yang Y, Li H, Li Z, et al. 2015. Size-exclusion HPLC provides a simple, rapid, and versatile alternative method for quality control of vaccines by characterizing the assembly of antigens. Vaccine 33:1143–1150.
  • Zhu Q, Li J, Liu H, et al. 2015. Development of stable water-in-oil emulsions using polyglycerol polyricinoleate and whey protein isolate and the impact on the quality of bittern-tofu. J Disperse Sci Technol. 36:1548–1555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.